ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,782 | -77.8% | 11,603 | -20.1% | 0.00% | – |
| Q2 2022 | $166,000 | +38.3% | 14,525 | +1.3% | 0.00% | – |
| Q1 2022 | $120,000 | -36.5% | 14,335 | +13.3% | 0.00% | – |
| Q4 2021 | $189,000 | -43.4% | 12,647 | -2.8% | 0.00% | – |
| Q3 2021 | $334,000 | -78.7% | 13,010 | -78.4% | 0.00% | -100.0% |
| Q2 2021 | $1,571,000 | -95.3% | 60,268 | -93.6% | 0.00% | -94.1% |
| Q1 2021 | $33,494,000 | +30.6% | 948,859 | -6.6% | 0.03% | +17.2% |
| Q4 2020 | $25,645,000 | -43.9% | 1,016,052 | -16.1% | 0.03% | -50.8% |
| Q3 2020 | $45,692,000 | -0.1% | 1,211,663 | +13.4% | 0.06% | -4.8% |
| Q2 2020 | $45,750,000 | +11453.0% | 1,068,448 | +5153.5% | 0.06% | – |
| Q1 2020 | $396,000 | +23.4% | 20,338 | +64.5% | 0.00% | – |
| Q4 2019 | $321,000 | +34.3% | 12,364 | +41.2% | 0.00% | – |
| Q3 2019 | $239,000 | – | 8,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |